Correction: Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
Yan Luo, Lei Liu, Yang Wu, Karnika Singh, Bing Su, Nan Zhang, Xiaowei Liu, Yangmei Shen, Shile Huang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPI3K/AKT/mTOR signaling in cancer
This article has been corrected: Following an investigation into concerns raised by a third party, we have identified image panel duplication involving the western blot for S6K1 and mSin1 blot in Figure 3B. Additionally, the GFP portion of the S6K1 blot in Figure 3B was duplicated to create a portion of the S6K1 blot in Figure 4B. The authors have agreed with the identified issues and stated that duplication of the S6K1 blot was inadvertently introduced during the preparation of Figures 3B and 4B for publication. The authors provided the raw, uncropped blots for mSin1 (related to Figure 3B) and S6K1 (related to Figure 4B) from their original experiments. They have also prepared corrected versions of Figures 3 and 4, where the mSin1 blot in Figure 3B and the GFP part of the S6K1 blot in Figure 4B have been replaced with the correct blots. The authors have stated that these corrections do not alter the original results or conclusions of the paper and apologized for any inconvenience caused. The corrected figures are listed below.
Original article: Oncotarget. 2015; 6:4286–4298. 4286-4298. https://doi.org/10.18632/oncotarget.3006